Zardaverine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Zardaverine
Zardaverine.svg
Names
IUPAC name
3-[4-(Difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one
Identifiers
3D model (JSmol)
ChemSpider
UNII
Properties
C12H10F2N2O3
Molar mass 268.220 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Zardaverine is a dual-selective PDE3/4 phosphodiesterase inhibitor.[1] Studies in vitro suggest that it may have useful anti-cancer properties.[2]

References[edit]

  1. ^ Kümmerle, AE; Schmitt, M; Cardozo, SV; Lugnier, C; Villa, P; Lopes, AB; Romeiro, NC; Justiniano, H; Martins, MA; Fraga, CA; Bourguignon, JJ; Barreiro, EJ (2012). "Design, Synthesis, and Pharmacological Evaluation of N-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 Inhibitors". Journal of Medicinal Chemistry. 55 (17): 7525–45. doi:10.1021/jm300514y. PMID 22891752.
  2. ^ Corsello SM, Nagari RT, Spangler RD, et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nature Cancer (2020). doi:10.1038/s43018-019-0018-6